Development of an RNase H2 Activity Assay for Clinical Screening.

Schulz, Marian Simon; Sartorius von Bach, Cay Bennet; Marinkovic, Emilija; Günther, Claudia; Behrendt, Rayk; Roers, Axel

Schulz, Marian Simon; Sartorius von Bach, Cay Bennet; Marinkovic, Emilija; Günther, Claudia; Behrendt, Rayk; Roers, Axel.

Afiliación

Schulz MS; University Hospital for Children and Adolescents, University of Leipzig, 04103 Leipzig, Germany.
Sartorius von Bach CB; Institute for Immunology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Marinkovic E; Institute for Immunology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Günther C; Department of Dermatology, University Hospital Carl Gustav Carus Dresden, TU Dresden, 01307 Dresden, Germany.
Behrendt R; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany.
Roers A; Institute for Immunology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

J Clin Med ; 12(4)2023 Feb 17.

Article en En | MEDLINE | ID: mdl-36836134

Palabras clave

DNA damage; RNase H2; assay validation; biomarker; cancer; chronic inflammation; clinical screening; fluorometric assay; interferonopathy; systemic lupus erythemathosus; systemic sclerosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google